You are currently viewing a new version of our website. To view the old version click .

Liquid Biopsy in Solid Tumors

Special Issue Information

Dear Colleagues,

Liquid biopsies represent one of the most exciting revolutions of the predictive molecular pathology era. The term 'liquid biopsy' refers to test that are carried out on a number of different biological fluids, including but not limited to plasma, cefalorachidian liquid, effusions and urine. The application of next generation technology to liquid biopsies has allowed for a quantum leap in the detection and monitoring of different genetic alterations, and it has become one of the key weapons able to improve the clinical outcome of different cancer patients.

In this Special Issue, we would like to discuss new insights into the liquid biopsy landscape that may be useful to improve the diagnosis, prognosis and treatment of solid tumours, with a special focus on the application of next-generation technologies to different types of liquid biopsy-derived analytes.

Dr. Umberto Malapelle
Dr. Francesco Passiglia
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Molecular Pathology is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • liquid biopsy
  • solid tumors
  • next-generation technologies
  • target treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Mol. Pathol. - ISSN 2673-5261